Bibliographie (2546)
AHA Scientific Statement: Obstructive Sleep Apnea and Cardiovascular Disease.
mercredi, 23 juin 2021 13:39 Écrit par Zouhair SouissiObstructive Sleep Apnea and Cardiovascular Disease: A Scientific Statement From the American Heart Association – Circulation News Release: Sleep apnea worsens heart disease, yet often untreated – American Heart Association
The post AHA Scientific Statement: Obstructive Sleep Apnea and Cardiovascular Disease. appeared first on Links Medicus.
The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-analysis, GRADE Assessment, and International Consensus Approach.
mercredi, 23 juin 2021 13:39 Écrit par Zouhair SouissiThe Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-analysis, GRADE Assessment, and International Consensus Approach – The Journal of Allergy and Clinical Immunology: In Practice
The post The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-analysis, GRADE Assessment, and International Consensus Approach. appeared first on Links Medicus.
New Analysis reveals link between birthdays and COVID-19 spread during the height of the pandemic.
mercredi, 23 juin 2021 13:39 Écrit par Zouhair SouissiNews release: New Analysis reveals link between birthdays and COVID-19 spread during the height of the pandemic – Harvard Medical School Original Study: Assessing the Association Between Social Gatherings and COVID-19 Risk Using Birthdays – JAMA Internal Medicine Commentary on Twitter (thread – click for more) The link between birthdays and Covid-19 Thread on […]
The post New Analysis reveals link between birthdays and COVID-19 spread during the height of the pandemic. appeared first on Links Medicus.
Interactive Infographic | Interpreting a lateral flow SARS-CoV-2 antigen test – “This calculator demonstrates how interpreting a covid-19 lateral flow device (LFD) result varies according to the pre-test probability, and the sensitivity and specificity of
mercredi, 23 juin 2021 13:39 Écrit par Zouhair SouissiInterpreting a lateral flow SARS-CoV-2 antigen test – The BMJ
The post Interactive Infographic | Interpreting a lateral flow SARS-CoV-2 antigen test – “This calculator demonstrates how interpreting a covid-19 lateral flow device (LFD) result varies according to the pre-test probability, and the sensitivity and specificity of the LFD used”. appeared first on Links Medicus.
Delta coronavirus variant: scientists brace for impact.
mercredi, 23 juin 2021 13:39 Écrit par Zouhair SouissiDelta coronavirus variant: scientists brace for impact – Nature
The post Delta coronavirus variant: scientists brace for impact. appeared first on Links Medicus.
Laboratory testing for suspected COVID-19 vaccine–induced (immune) thrombotic thrombocytopenia.
mercredi, 23 juin 2021 13:39 Écrit par Zouhair SouissiLaboratory testing for suspected COVID-19 vaccine–induced (immune) thrombotic thrombocytopenia – International Journal of Laboratory Hematology
The post Laboratory testing for suspected COVID-19 vaccine–induced (immune) thrombotic thrombocytopenia. appeared first on Links Medicus.
![[News release – not published yet] COVID-19 outpatient thrombosis prevention trial ends early – “Results suggest that not treating certain symptomatic but stable outpatients with anticoagulant or antiplatelet therapy may be the best course of action”.](/media/k2/items/cache/ee9bc87b420b756ad4171d9571626ba4_S.jpg)
[News release – not published yet] COVID-19 outpatient thrombosis prevention trial ends early – “Results suggest that not treating certain symptomatic but stable outpatients with anticoagulant or antiplatelet therapy may be the best course of action”.
mercredi, 23 juin 2021 13:39 Écrit par Zouhair SouissiNIH ACTIV-4B COVID-19 outpatient thrombosis prevention trial ends earl – Brigham and Women’s Hospital Commentary: Antithrombotics No Help for Stable COVID-19 Outpatients: ACTIV-4b – TCTMD
The post [News release – not published yet] COVID-19 outpatient thrombosis prevention trial ends early – “Results suggest that not treating certain symptomatic but stable outpatients with anticoagulant or antiplatelet therapy may be the best course of action”. appeared first on Links Medicus.
Case report: Multisystem inflammatory syndrome in an adult after SARS-CoV-2 infection.
mardi, 22 juin 2021 13:17 Écrit par Zouhair SouissiMultisystem inflammatory syndrome in an adult after SARS-CoV-2 infection – Canadian Medical Association Journal Commentary: COVID-19-related multisystem inflammatory syndrome in adults: Rare but possible – Canadian Medical Association Journal
The post Case report: Multisystem inflammatory syndrome in an adult after SARS-CoV-2 infection. appeared first on Links Medicus.
Perspective | COVID-19: The rise and rise of Delta.
mardi, 22 juin 2021 13:17 Écrit par Zouhair SouissiCOVID-19: The rise and rise of Delta – Sciblogs
The post Perspective | COVID-19: The rise and rise of Delta. appeared first on Links Medicus.
Ivermectin is the new hydroxychloroquine, take 2 – “Ivermectin shouldn’t be used to treat COVID-19 outside of the context of a well-designed clinical trial”.
mardi, 22 juin 2021 13:17 Écrit par Zouhair SouissiIvermectin is the new hydroxychloroquine, take 2 – Science-Based Medicine Related: [Preprint] Meta-analysis of RCT: Ivermectin for the treatment of COVID-19 – no effect on all-cause mortality, length of stay, or viral clearance AND M-A: Prophylaxis against Covid-19: 1 – no benefit from Hydroxychloroquine; 2 – as studies on ivermectin so far have been small, […]
The post Ivermectin is the new hydroxychloroquine, take 2 – “Ivermectin shouldn’t be used to treat COVID-19 outside of the context of a well-designed clinical trial”. appeared first on Links Medicus.
![[Preprint] Rapid displacement of SARS-CoV-2 variant B.1.1.7 (Alpha) by B.1.617.2 (Delta) and P.1 (Gamma) in the United States.](/media/k2/items/cache/b7e870fe16253b03d4f5e4eca7c887cf_XS.jpg)
